Search
Coya Therapeutics Inc
COYAAdd to Watchlist
5.860USD
+0.200+3.53%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
137.46MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Coya Therapeutics Inc is 8.33, ranking 137 out of 387 in the Biotechnology & Medical Research industry. The average price target is 16.00, with a high of 18.00 and a low of 14.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
15.750
Target Price
+159.47%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Coya Therapeutics Inc
COYA
6
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Coya Therapeutics Inc's expected revenue for the next quarter?
Coya Therapeutics Inc's expected revenue is 100.00K.
What is Coya Therapeutics Inc's price target?
Analysts forecast that Coya Therapeutics Inc's price target is USD 16.00, with the highest forecast at USD 18.00 and the lowest forecast at USD 14.00.
How have Coya Therapeutics IncCOYA's recent earnings per share performed?
The market expectation was USD -0.32, while Coya Therapeutics IncCOYA's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.34.
What is the analyst rating for Coya Therapeutics Inc?
Based on the ratings of Coya Therapeutics Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.